{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:03:55Z","timestamp":1789473835630,"version":"build-2803163510"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T00:00:00Z","timestamp":1637020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background and aims:<\/jats:bold> Hepatitis B virus-associated acute-on-chronic liver failure (HBV-ACLF) is a complicated syndrome with extremely high short-term mortality. Whether plasma exchange (PE) improves HBV-ACLF outcomes remains controversial. Here, PE-based non-bioartificial liver support system (NB-ALSS) effects on short-term HBV-ACLF patient outcomes were investigated.<\/jats:p><jats:p><jats:bold>Materials and methods:<\/jats:bold> HBV-ACLF patients from Chinese Acute-on-chronic Liver Failure (CATCH-LIFE) cohort receiving standard medical therapy (SMT) alone or PE-based NB-ALSS in addition to SMT were allocated to SMT and SMT+PE groups, respectively; propensity score matching (PSM) was used to eliminate confounding bias. Short-term (28\/90-day and 1-year) survival rates were calculated (Kaplan-Meier).<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> In total, 524 patients with HBV-ACLF were enrolled in this study; 358 received SMT alone (SMT group), and the remaining 166 received PE-based NB-ALSS in addition to SMT (SMT+PE group). PSM generated 166 pairs of cases. In the SMT+PE group, 28-day, 90-day, and 1-year survival rates were 11.90, 8.00, and 10.90%, respectively, higher than those in the SMT group. Subgroup analysis revealed that PE-based NB-ALSS had the best efficacy in patients with ACLF grade 2 or MELD scores of 30\u201340 (MELD grade 3). In MELD grade 3 patients who received SMT+PE, 28-day, 90-day, and 1-year survival rates were improved by 18.60, 14.20, and 20.10%, respectively. According to multivariate Cox regression analysis, PE-based NB-ALSS was the only independent protective factor for HBV-ACLF patient prognosis at 28 days, 90 days, and 1 year (28 days, HR = 0.516, <jats:italic>p<\/jats:italic> = 0.001; 90 days, HR = 0.663, <jats:italic>p<\/jats:italic> = 0.010; 1 year, HR = 0.610, <jats:italic>p<\/jats:italic> = 0.051). For those who received SMT+PE therapy, PE-based NB-ALSS therapy frequency was the only independent protective factor for short-term prognosis (28-day, HR = 0.597, <jats:italic>p<\/jats:italic> = 0.001; 90-day, HR = 0.772, <jats:italic>p<\/jats:italic> = 0.018).<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> This multicenter prospective study showed that the addition of PE-based NB-ALSS to SMT improves short-term (28\/90 days and 1-year) outcomes in patients with HBV-ACLF, especially in MELD grade 3 patients. Optimization of PE-based NB-ALSS may improve prognosis or even save lives among HBV-ACLF patients.<\/jats:p>","DOI":"10.3389\/fmed.2021.779744","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T14:49:43Z","timestamp":1685458183000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Plasma Exchange-Based Non-bioartificial Liver Support System Improves the Short-Term Outcomes of Patients With Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure: A Multicenter Prospective Cohort Study"],"prefix":"10.3389","volume":"8","author":[{"given":"Yuan-yuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-yan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei-ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-hang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-ping","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-bo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-ji","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Chinese Chronic Liver Failure (CLIF) Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrgastro.2015.219","article-title":"Acute-on-chronic liver failure: terminology, mechanisms and management","volume":"13","author":"Sarin","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1007\/s11684-017-0598-4","article-title":"Current advances in the elimination of hepatitis B in China by 2030","volume":"11","author":"Zhang","year":"2017","journal-title":"Front Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12985-016-0536-0","article-title":"Changing etiologies and outcome of liver failure in Southwest China","volume":"13","author":"Xie","year":"2016","journal-title":"Virol J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"gutjnl\u20132020","DOI":"10.1136\/gutjnl-2020-322161","article-title":"Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis","volume":"2021","author":"Mezzano","year":"2021","journal-title":"Gut."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1136\/gutjnl-2017-314641","article-title":"Development of diagnostic criteria and a prognostic score for hepatitis B virus-related acute-on-chronic liver failure","volume":"67","author":"Wu","year":"2018","journal-title":"Gut."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology."},{"key":"B8","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/hep.27795","article-title":"Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults","volume":"62","author":"Shi","year":"2015","journal-title":"Hepatology."},{"key":"B9","doi-asserted-by":"publisher","first-page":"25487","DOI":"10.1038\/srep25487","article-title":"Characteristics, diagnosis and prognosis of acute-on-chronic liver failure in cirrhosis associated to hepatitis B","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep."},{"key":"B10","doi-asserted-by":"publisher","first-page":"gutjnl\u20132020","DOI":"10.1136\/gutjnl-2020-323395","article-title":"PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF","volume":"2021","author":"Li","year":"2021","journal-title":"Gut."},{"key":"B11","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J Hepatol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.20524\/aog.2017.0178","article-title":"Bacterial translocation markers in liver cirrhosis","volume":"30","author":"Alexopoulou","year":"2017","journal-title":"Ann Gastroenterol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41575-020-00376-3","article-title":"Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure","volume":"18","author":"Trebicka","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jhep.2019.11.009","article-title":"Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF","volume":"72","author":"Moreau","year":"2020","journal-title":"J Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jhep.2020.11.048","article-title":"The systemic inflammation hypothesis: towards a new paradigm of acute decompensation and multiorgan failure in cirrhosis","volume":"74","author":"Arroyo","year":"2021","journal-title":"J Hepatol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"122632","DOI":"10.3390\/cells9122632","article-title":"Leukocytes, systemic inflammation and immunopathology in acute-on-chronic liver failure","volume":"9","author":"Casulleras","year":"2020","journal-title":"Cells."},{"key":"B17","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2020.06.013","article-title":"The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology","volume":"73","author":"Trebicka","year":"2020","journal-title":"J Hepatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ajt.13197","article-title":"OPTN\/SRTR 2013 annual data report: liver","volume":"15","author":"Kim","year":"2015","journal-title":"Am J Transplant."},{"key":"B19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/ajt.15678","article-title":"OPTN\/SRTR 2018 annual data report: deceased organ donation","volume":"20","author":"Israni","year":"2020","journal-title":"Am J Transplant."},{"key":"B20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10238-011-0160-7","article-title":"Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure","volume":"12","author":"Chen","year":"2011","journal-title":"Clin Exp Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/j.1440-1746.2009.06089.x","article-title":"Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure","volume":"25","author":"Sun LJ Yu","year":"2010","journal-title":"J Gastroenterol Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jhep.2015.08.018","article-title":"High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial","volume":"64","author":"Larsen","year":"2016","journal-title":"J Hepatol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000014407","article-title":"Effect of plasma exchange on serum tissue inhibitor of metalloproteinase 1 and cytokine concentrations in patients with fulminant hepatitis","volume":"18","author":"Nakamura","year":"2000","journal-title":"Blood Purif."},{"key":"B24","first-page":"65","article-title":"Are proinflammatory cytokine concentrations reduced by plasma exchange in patients with severe acute hepatic failure?","volume":"109","author":"Nakae","year":"2001","journal-title":"Res Commun Mol Pathol Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1007\/s12072-015-9667-4","article-title":"The effect of plasma exchange on entecavir-treated chronic hepatitis B patients with hepatic de-compensation and acute-on-chronic liver failure","volume":"10","author":"Yue-Meng","year":"2016","journal-title":"Hepatol Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1440-1746.2008.05484.x","article-title":"Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment","volume":"23","author":"Yu","year":"2008","journal-title":"J Gastroenterol Hepatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.transci.2018.05.030","article-title":"Prognostic factors and treatment effect of standard-volume plasma exchange for acute and acute-on-chronic liver failure: a single-center retrospective study","volume":"57","author":"Cheng","year":"2018","journal-title":"Transfus Apher Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3109\/09563070400003714","article-title":"Short-term survival advantage after plasma exchange in the treatment of acute on chronic liver failure or acute liver failure","volume":"15","author":"Hung","year":"2011","journal-title":"Clinical Intensive Care."},{"key":"B29","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/jca.21799","article-title":"Therapeutic plasma exchange in acute on chronic liver failure","volume":"35","author":"Stahl","year":"2020","journal-title":"J Clin Apher."},{"key":"B30","doi-asserted-by":"publisher","first-page":"300060520932053","DOI":"10.1177\/0300060520932053","article-title":"Comparison of plasma exchange, double plasma molecular adsorption system, and their combination in treating acute-on-chronic liver failure","volume":"48","author":"Guo","year":"2020","journal-title":"J Int Med Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3748\/wjg.v26.i2.219","article-title":"Plasma exchange in patients with acute and acute-on-chronic liver failure: a systematic review","volume":"26","author":"Tan","year":"2020","journal-title":"World J Gastroenterol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13613-020-00795-0","article-title":"Uncertainty in the impact of liver support systems in acute-on-chronic liver failure: a systematic review and network meta-analysis","volume":"11","author":"Ocskay","year":"2021","journal-title":"Ann Intens Care."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e037793","DOI":"10.1136\/bmjopen-2020-037793","article-title":"Cohort profile: a multicentre prospective validation cohort of the Chinese Acute-on-Chronic Liver Failure (CATCH-LIFE) study","volume":"11","author":"Qiao","year":"2021","journal-title":"BMJ Open."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1093\/aje\/kwy083","article-title":"Acute-on-chronic liver failure in China: rationale for developing a patient registry and baseline characteristics","volume":"187","author":"Gu","year":"2018","journal-title":"Am J Epidemiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc","year":"2000","journal-title":"Hepatology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1053\/j.gastro.2014.05.005","article-title":"Toward an improved definition of acute-on-chronic liver failure","volume":"147","author":"Jalan","year":"2014","journal-title":"Gastroenterology."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis","volume":"101","author":"Bone","year":"1992","journal-title":"ACCP\/SCCM Consensus Conference Committee American College of Chest Physicians\/Society of Critical Care Medicine Chest."},{"key":"B38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s12072-020-10053-x","article-title":"Plasma perfusion combined with plasma exchange in chronic hepatitis B-related acute-on-chronic liver failure patients","volume":"14","author":"Yang","year":"2020","journal-title":"Hepatol Int."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1097\/CCM.0000000000002562","article-title":"Molecular adsorbent recirculating system can reduce short-term mortality among patients with acute-on-chronic liver failure-a retrospective analysis","volume":"45","author":"Gerth","year":"2017","journal-title":"Crit Care Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.27406","article-title":"The global burden of liver disease: the major impact of China","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology."},{"key":"B41","doi-asserted-by":"publisher","first-page":"442","DOI":"10.5301\/ijao.5000341","article-title":"A single-center experience of non-bioartificial liver support systems among Chinese patients with liver failure","volume":"37","author":"Xia","year":"2014","journal-title":"Int J Artif Organs."},{"key":"B42","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S1499-3872(16)60084-X","article-title":"Plasma exchange-centered artificial liver support system in hepatitis B virus-related acute-on-chronic liver failure: a nationwide prospective multicenter study in China","volume":"15","author":"Chen","year":"2016","journal-title":"Hepatobiliary Pancreatic Dis Int."},{"key":"B43","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/jca.21690","article-title":"Therapeutic effect of double plasma molecular adsorption system and sequential half-dose plasma exchange in patients with HBV-related acute-on-chronic liver failure","volume":"34","author":"Yao","year":"2019","journal-title":"J Clin Apher."},{"key":"B44","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s12072-019-09946-3","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update","volume":"13","author":"Sarin","year":"2019","journal-title":"Hepatol Int."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/liv.14806","article-title":"Therapeutic plasma-exchange improves systemic inflammation and survival in acute-on-chronic liver failure: a propensity-score matched study from AARC","volume":"41","author":"Maiwall","year":"2021","journal-title":"Liver Int."},{"key":"B46","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1182\/blood-2016-01-635003","article-title":"How i treat patients with a history of heparin-induced thrombocytopenia","volume":"128","author":"Warkentin","year":"2016","journal-title":"Blood."},{"key":"B47","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1182\/blood-2018-05-850370","article-title":"Fibronectin modulates formation of PF4\/heparin complexes and is a potential factor for reducing risk of developing HIT","volume":"133","author":"Krauel","year":"2019","journal-title":"Blood."},{"key":"B48","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/jca.21737","article-title":"Therapeutic plasma exchange in acute liver failure","volume":"34","author":"Stahl","year":"2019","journal-title":"J Clin Apher."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.779744\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T14:49:48Z","timestamp":1685458188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.779744\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,16]]},"references-count":48,"alternative-id":["10.3389\/fmed.2021.779744"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.779744","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,16]]},"article-number":"779744"}}